Your session is about to expire
← Back to Search
Digital Memory Notebook for Cognitive Impairment (DMN Trial)
N/A
Waitlist Available
Led By Sarah Farias, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1, week 8, and week 12
Awards & highlights
DMN Trial Summary
This trial is testing whether the Digital Memory Notebook, a tablet-based app, can help older adults with mild cognitive impairment or subjective cognitive complaints complete everyday tasks.
Who is the study for?
This trial is for English-speaking adults aged 60 or older with mild cognitive impairment (MCI) or subjective cognitive complaints (SCC). They must have someone to help with surveys. Pregnant women, those unable to consent, and prisoners are excluded.Check my eligibility
What is being tested?
The study tests a Digital Memory Notebook app designed to aid daily tasks for people with memory issues. It involves a 6-week training on using the app followed by a 4-week period of regular use, with assessments before and after the intervention.See study design
What are the potential side effects?
Since this trial involves using an application rather than medication, traditional side effects are not expected. However, participants may experience frustration or difficulty adapting to new technology.
DMN Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 1, week 8, and week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1, week 8, and week 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Real-time data extracted from the DMN Application
Secondary outcome measures
Participant Questionnaire Outcomes
DMN Trial Design
1Treatment groups
Experimental Treatment
Group I: DMN InterventionExperimental Treatment1 Intervention
Subjects will attend 2-hour weekly sessions for 6- weeks. Participants will continue to use the DMN application for 4-weeks after the intervention is complete.
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
910 Previous Clinical Trials
4,706,971 Total Patients Enrolled
Sarah Farias, PhDPrincipal InvestigatorUniversity of California, Davis
1 Previous Clinical Trials
225 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with memory problems or mild forgetfulness.You must be at least 60 years old to participate, with no upper age limit.
Research Study Groups:
This trial has the following groups:- Group 1: DMN Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Alzheimer's Disease Patient Testimony for trial: Trial Name: NCT04240665 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still an opportunity for individuals to participate in this investigative trial?
"Evidently, this study is not currently recruiting patients. It was initially posted on November 11th 2020 and its contents were last amended on February 17th 2022. Despite the lack of recruitment for this particular trial, there are still 983 other medical trials that require participants right now."
Answered by AI
Who else is applying?
What state do they live in?
California
What site did they apply to?
Alzheimer's Disease Center, University of California, Davis
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
I am hoping allow this trial can address or help me function better on a daily basis without relying on others.
PatientReceived 1 prior treatment
What questions have other patients asked about this trial?
I live in Stockton, not too far from UC Davis Medical in Sacramento. How often will we need to travel to Sacramento?
PatientReceived 1 prior treatment
Recent research and studies
Share this study with friends
Copy Link
Messenger